Mark R Ferguson1,2, Sandra L Poliachik1, Christopher B Budech1, Nancy E Gove3, Gregory T Carter4, Leo H Wang5, Daniel G Miller6, Dennis W W Shaw1,2, Seth D Friedman1. 1. Department of Radiology, Seattle Children's Hospital, 4800 Sandpoint Way, Room: L-MA.6.226, Seattle, Washington, 98105, USA. 2. Department of Radiology, University of Washington, Seattle, Washington, USA. 3. Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington, USA. 4. St Luke's Rehabilitation Institute, Spokane, Washington, USA. 5. Department of Neurology, University of Washington, Seattle, Washington, USA. 6. Genome Sciences, University of Washington, Seattle, Washington, USA.
Abstract
INTRODUCTION: MRI evaluation in facioscapulohumeral muscular dystrophy (FSHD) demonstrates fatty replacement and inflammation/edema in muscle. Our previous work demonstrated short T1 inversion recovery (STIR)-hyperintense (STIR+) signal in muscle 2 years before fatty replacement. We evaluated leg muscle STIR changes and fatty replacement within 14 months. METHODS: FSHD subjects received 2 MRI scans of thigh and calf over a 6.9- to 13.8-month interval. Quality of life measures were collected. One Radiologist rated muscle changes on a semi-quantitative scale. RESULTS: Fifteen subjects completed longitudinal imaging. Four STIR + muscles and 3 STIR-normal (STIR-) muscles were rated as progressing to fatty tissue over the study period. DISCUSSION: STIR + muscles with confluent regions of fat at baseline increased more in fat, while STIR- muscles had increases in septal-fat over the study period. These changes may reflect two phases of FSHD, demonstrating MRI sensitivity is weighted toward gross pathological phases of the disease. Muscle Nerve 57: 905-912, 2018.
INTRODUCTION: MRI evaluation in facioscapulohumeral muscular dystrophy (FSHD) demonstrates fatty replacement and inflammation/edema in muscle. Our previous work demonstrated short T1 inversion recovery (STIR)-hyperintense (STIR+) signal in muscle 2 years before fatty replacement. We evaluated leg muscle STIR changes and fatty replacement within 14 months. METHODS:FSHD subjects received 2 MRI scans of thigh and calf over a 6.9- to 13.8-month interval. Quality of life measures were collected. One Radiologist rated muscle changes on a semi-quantitative scale. RESULTS: Fifteen subjects completed longitudinal imaging. Four STIR + muscles and 3 STIR-normal (STIR-) muscles were rated as progressing to fatty tissue over the study period. DISCUSSION: STIR + muscles with confluent regions of fat at baseline increased more in fat, while STIR- muscles had increases in septal-fat over the study period. These changes may reflect two phases of FSHD, demonstrating MRI sensitivity is weighted toward gross pathological phases of the disease. Muscle Nerve 57: 905-912, 2018.
Authors: Chao-Jen Wong; Leo Wang; V Michael Holers; Ashley Frazer-Abel; Silvère M van der Maarel; Rabi Tawil; Jeffrey M Statland; Stephen J Tapscott Journal: Hum Mol Genet Date: 2022-06-04 Impact factor: 5.121
Authors: Amy E Campbell; Andrea E Belleville; Rebecca Resnick; Sean C Shadle; Stephen J Tapscott Journal: Hum Mol Genet Date: 2018-08-01 Impact factor: 6.150
Authors: Leo H Wang; Laura M Johnstone; Michael Bindschadler; Stephen J Tapscott; Seth D Friedman Journal: BMC Musculoskelet Disord Date: 2021-01-09 Impact factor: 2.362
Authors: Leo H Wang; Dennis W W Shaw; Anna Faino; Christopher B Budech; Leann M Lewis; Jeffrey Statland; Katy Eichinger; Stephen J Tapscott; Rabi N Tawil; Seth D Friedman Journal: BMC Musculoskelet Disord Date: 2021-03-10 Impact factor: 2.362